| dc.contributor.author | Maurya, Ranjani | |
| dc.contributor.author | Soni, Awakash | |
| dc.contributor.author | Anand, Devireddy | |
| dc.contributor.author | Ravi, Makthala | |
| dc.contributor.author | Raju, K S R | |
| dc.contributor.author | Taneja, Isha | |
| dc.contributor.author | Naikade, N K | |
| dc.contributor.author | Puri, S K | |
| dc.contributor.author | Wahajuddin | |
| dc.contributor.author | Kanojiya, Sanjeev | |
| dc.contributor.author | Yadav, P P | |
| dc.date.accessioned | 2013-03-06T06:27:38Z | |
| dc.date.available | 2013-03-06T06:27:38Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | ACS Medicinal Chemistry Letters, 2013, 4 (2), 165–169 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1008 | |
| dc.description.abstract | Novel 3,3-spiroanellated 5-aryl, 6-arylvinyl substituted 1,2,4-trioxanes 19-34 have been syn-thesized and appraised for their antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in swiss mice by oral route at the doses ranging from 96 mg/kg x 4 days to 24 mg/kg x 4 days. 1,2,4-trioxane 25 the most active compounds of the series, provided 100% protection at 24 mg/kg x 4 days and other 1,2,4-trioxanes 22, 26, 27 and 30 also showed promising activity. In this model β-arteether provided 100% and 20% protection at 48 mg/kg x 4 days and 24 mg/kg x 4 days, respectively by oral route. | en |
| dc.format.extent | 232406 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CDRI communication no. 8341 | en |
| dc.subject | 1,2,4-trioxane | en |
| dc.subject | Antimalarial | en |
| dc.subject | In-vivo | en |
| dc.subject | Orally active | en |
| dc.title | Synthesis and Antimalarial activity of 3,3-spiroanellated 5,6-disubstituted-1,2,4-trioxanes | en |
| dc.type | Article | en |